Cargando…

Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants

We developed a spatially structured, fully stochastic, individual-based SARS-CoV-2 transmission model to evaluate the feasibility of sustaining SARS-CoV-2 local containment in mainland China considering currently dominant Omicron variants, China’s current immunization level, and non-pharmaceutical i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Sun, Kaiyuan, Feng, Zhaomin, Yi, Lan, Wu, Yanpeng, Liu, Hengcong, Wang, Quanyi, Ajelli, Marco, Viboud, Cécile, Yu, Hongjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128785/
https://www.ncbi.nlm.nih.gov/pubmed/35611330
http://dx.doi.org/10.1101/2022.05.07.22274792
_version_ 1784712618216259584
author Wang, Yan
Sun, Kaiyuan
Feng, Zhaomin
Yi, Lan
Wu, Yanpeng
Liu, Hengcong
Wang, Quanyi
Ajelli, Marco
Viboud, Cécile
Yu, Hongjie
author_facet Wang, Yan
Sun, Kaiyuan
Feng, Zhaomin
Yi, Lan
Wu, Yanpeng
Liu, Hengcong
Wang, Quanyi
Ajelli, Marco
Viboud, Cécile
Yu, Hongjie
author_sort Wang, Yan
collection PubMed
description We developed a spatially structured, fully stochastic, individual-based SARS-CoV-2 transmission model to evaluate the feasibility of sustaining SARS-CoV-2 local containment in mainland China considering currently dominant Omicron variants, China’s current immunization level, and non-pharmaceutical interventions (NPIs). We also built a statistical model to estimate the overall disease burden under various hypothetical mitigation scenarios. We found that due to high transmissibility, neither Omicron BA.1 or BA.2 could be contained by China’s pre-Omicron NPI strategies which were successful prior to the emergence of the Omicron variants. However, increased intervention intensity, such as enhanced population mobility restrictions and multi-round mass testing, could lead to containment success. We estimated that an acute Omicron epidemic wave in mainland China would result in significant number of deaths if China were to reopen under current vaccine coverage with no antiviral uptake, while increasing vaccination coverage and antiviral uptake could substantially reduce the disease burden. As China’s current vaccination has yet to reach high coverage in older populations, NPIs remain essential tools to maintain low levels of infection while building up protective population immunity, ensuring a smooth transition out of the pandemic phase while minimizing the overall disease burden.
format Online
Article
Text
id pubmed-9128785
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-91287852022-05-25 Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants Wang, Yan Sun, Kaiyuan Feng, Zhaomin Yi, Lan Wu, Yanpeng Liu, Hengcong Wang, Quanyi Ajelli, Marco Viboud, Cécile Yu, Hongjie medRxiv Article We developed a spatially structured, fully stochastic, individual-based SARS-CoV-2 transmission model to evaluate the feasibility of sustaining SARS-CoV-2 local containment in mainland China considering currently dominant Omicron variants, China’s current immunization level, and non-pharmaceutical interventions (NPIs). We also built a statistical model to estimate the overall disease burden under various hypothetical mitigation scenarios. We found that due to high transmissibility, neither Omicron BA.1 or BA.2 could be contained by China’s pre-Omicron NPI strategies which were successful prior to the emergence of the Omicron variants. However, increased intervention intensity, such as enhanced population mobility restrictions and multi-round mass testing, could lead to containment success. We estimated that an acute Omicron epidemic wave in mainland China would result in significant number of deaths if China were to reopen under current vaccine coverage with no antiviral uptake, while increasing vaccination coverage and antiviral uptake could substantially reduce the disease burden. As China’s current vaccination has yet to reach high coverage in older populations, NPIs remain essential tools to maintain low levels of infection while building up protective population immunity, ensuring a smooth transition out of the pandemic phase while minimizing the overall disease burden. Cold Spring Harbor Laboratory 2022-06-06 /pmc/articles/PMC9128785/ /pubmed/35611330 http://dx.doi.org/10.1101/2022.05.07.22274792 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Wang, Yan
Sun, Kaiyuan
Feng, Zhaomin
Yi, Lan
Wu, Yanpeng
Liu, Hengcong
Wang, Quanyi
Ajelli, Marco
Viboud, Cécile
Yu, Hongjie
Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants
title Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants
title_full Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants
title_fullStr Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants
title_full_unstemmed Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants
title_short Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants
title_sort assessing the feasibility of sustaining sars-cov-2 local containment in china in the era of highly transmissible variants
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128785/
https://www.ncbi.nlm.nih.gov/pubmed/35611330
http://dx.doi.org/10.1101/2022.05.07.22274792
work_keys_str_mv AT wangyan assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants
AT sunkaiyuan assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants
AT fengzhaomin assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants
AT yilan assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants
AT wuyanpeng assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants
AT liuhengcong assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants
AT wangquanyi assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants
AT ajellimarco assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants
AT viboudcecile assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants
AT yuhongjie assessingthefeasibilityofsustainingsarscov2localcontainmentinchinaintheeraofhighlytransmissiblevariants